tiprankstipranks
Trending News
More News >
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Income Statement

Compare
629 Followers

Cue Biopharma Income Statement

Last quarter (Q3 2025), Cue Biopharma's total revenue was $2.15M, a decrease of -35.58% from the same quarter last year. In Q3, Cue Biopharma's net income was $-7.45M. See Cue Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.29M$ 5.49M$ 1.25M$ 14.94M$ 3.15M
Gross Profit
$ 9.29M$ -32.61M$ 1.25M$ 16.72M$ -30.39M
Operating Expenses
$ 50.79M$ 19.54M$ 54.47M$ 60.43M$ 14.65M
Depreciation and Amortization
$ 2.35M$ 3.44M$ 1.81M$ -1.78M$ 1.06M
EBITDA
$ -37.53M$ -46.05M$ -50.49M$ -45.44M$ -43.99M
Operating Income
$ -41.50M$ -52.15M$ -53.23M$ -43.71M$ -45.04M
Other Income/Expenses
$ 826.00K$ 1.42M$ 215.00K$ 45.90K$ 463.91K
Pretax Income
$ -40.67M$ -50.73M$ -53.01M$ -43.67M$ -44.58M
Net Income
$ -40.67M$ -50.73M$ -53.01M$ -44.16M$ -44.78M
Per Share Metrics
Basic EPS
$ -0.72$ -1.11$ -1.49$ -1.41$ -1.56
Diluted EPS
$ -0.72$ -1.11$ -1.49$ -1.41$ -1.56
Weighted Average Shares Outstanding
56.33M 45.75M 35.65M 31.29M 28.69M
Weighted Average Shares Outstanding (Diluted)
56.33M 45.75M 35.65M 31.29M 28.69M
Currency in USD

Cue Biopharma Earnings and Revenue History